Answers are grounded in this paper and cite their sources.
Demonstrates improved prognostic stratification in early breast cancer, suggesting enhanced treatment decisions.
Gene expression signatures (GESs) are widely used for prognostic assessment and treatment stratification in breast cancer. Several integrative approaches now combine tumour proliferation, estrogen receptors signalling, immune activity, and clinicopathologic features. Machine learning (ML) approaches can further leverage these multi-dimensional molecular and clinical features to model complex relationships and improve prognostic stratification.
No takes yet. Share an insight, caveat, or question.
Sarafidis et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: